Ferucarbotran-Enhanced Hepatic MRI at 3T Unit: Quantitative and Qualitative Comparison of Fast Breathhold Imaging Sequences
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose : To compare the relative values of various fast breath-hold imaging sequences for superparamagnetic iron-oxide (SPIO)-enhanced hepatic MRI for the assessment of solid focal lesions with a 3T MRI unit. Materials and Methods : 102 consecutive patients with one or more solid malignant hepatic lesions were evaluated by spoiled gradient echo (GRE) sequences with three different echo times (2.4 msec [GRE_2.4], 5.8 msec [GRE_5.8], and 10 msec [GRE_10]) for T2*-weighted imaging in addition to T2-weighted turbo spin echo (TSE) sequence following intravenous SPIO injection. Image qualities of the hepatic contour, vascular landmarks and artifacts were rated by two independent readers using a four-point scale. For quantitative analysis, contrast-to-noise ratio (CNR) was measured in 170 solid focal lesions larger than 1 cm (107 hepatocellular carcinomas, nine cholangiocarcinomas and 54 metastases). Results : GRE_5.8 showed the highest mean points for hepatic contour, vascular anatomy and imaging artifact presence among all of the subjected sequences (p<0.001) and was comparable (p=0.414) with GRE_10 with regard to lesion conspicuity. The mean CNRs were significantly higher (p<0.001) in the following order: GRE_10 (24.4±14.5), GRE_5.8 (14.8±9.4), TSE (9.7±6.3), and GRE_2.4 (7.9±6.4). The mean CNRs of CCCs and metastases were higher than those of HCCs for all imaging sequences (p<0.05). Conclusion : Regarding overall performances, GRE using a moderate echo time of 5.8 msec can provide the most reliable data among the various fast breath-hold SPIOenhanced hepatic MRI sequences at 3T unit despite the lower CNR of GRE_5.8 compared to that of GRE_10.
Abstract
Purpose : To compare the relative values of various fast breath-hold imaging sequences for superparamagnetic iron-oxide (SPIO)-enhanced hepatic MRI for the assessment of solid focal lesions with a 3T MRI unit. Materials and Methods : 102 consecutive patients with one or more solid malignant hepatic lesions were evaluated by spoiled gradient echo (GRE) sequences with three different echo times (2.4 msec [GRE_2.4], 5.8 msec [GRE_5.8], and 10 msec [GRE_10]) for T2*-weighted imaging in addition to T2-weighted turbo spin echo (TSE) sequence following intravenous SPIO injection. Image qualities of the hepatic contour, vascular landmarks and artifacts were rated by two independent readers using a four-point scale. For quantitative analysis, contrast-to-noise ratio (CNR) was measured in 170 solid focal lesions larger than 1 cm (107 hepatocellular carcinomas, nine cholangiocarcinomas and 54 metastases). Results : GRE_5.8 showed the highest mean points for hepatic contour, vascular anatomy and imaging artifact presence among all of the subjected sequences (p<0.001) and was comparable (p=0.414) with GRE_10 with regard to lesion conspicuity. The mean CNRs were significantly higher (p<0.001) in the following order: GRE_10 (24.4±14.5), GRE_5.8 (14.8±9.4), TSE (9.7±6.3), and GRE_2.4 (7.9±6.4). The mean CNRs of CCCs and metastases were higher than those of HCCs for all imaging sequences (p<0.05). Conclusion : Regarding overall performances, GRE using a moderate echo time of 5.8 msec can provide the most reliable data among the various fast breath-hold SPIOenhanced hepatic MRI sequences at 3T unit despite the lower CNR of GRE_5.8 compared to that of GRE_10.
참고문헌 (29)
- Van Beers BE, "Contrast-enhanced MR iaging of the liver", Radiology, 203, pp.297~306 (1997)
- Reimer P, "Hepatic MRI with SPIO: detection and characterization of focal liver lesions", Eur Radiol, 8, pp.1198~1204 (1998)
- von Falkenhausen M, "Intraindividual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T", Eur Radiol, 17, pp.1256~1261 (2007)
- Chang JM, "Superparamagnetic iron oxide-enhanced liver magnetic resonance imaging-comparison of 1.5T and 3.0T imaging for detection of focal malignant liver lesions", Invest Radiol, 41, pp.168~174 (2006)
- Ramalho M, "Zapparoli M, Semelka R. Liver MR imaging: 1.5T versus 3T", Magn Reson Imaging Clin N Am, 15, pp.321~347 (2007)
- von Falkenhausen MM, "High-field-strength MR imaging of the liver at 3.0T: Intraindividual comparative study with MR imaging at 1.5T", Radiology, 241, pp.156~166 (2006)
- Kim T, "Effect of superparamagnetic iron oxide on tumor-to-liver contrast at T2*-weighted gradient-echo MRI:comparison between 3.0T and 1.5T MR systems", J Magn Reson Imaging, 29, pp.595~600 (2009)
- Nakada T, "Clinical Experience on 3.0T systems in Niigata, 1996 to 2002", Invest Radiol, 38, pp.377~384 (2003)
- Ward J, "Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging-comparison of optimized sequences", Radiology, 228, pp.709~718 (2003)
- Kim MJ, "Optimal TE for SPIOenhanced gradient-recalled echo MRI for the detection of focal hepatic lesions", AJR Am J Roentgenol, 187, pp.W255~W266 (2006)
- de Bazelaire CM, "MR Imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0T : preliminary results", Radiology, 230, pp.652~659 (2004)
- Bottomley PA, "A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age", Med Phys, 11, pp.425~448 (1984)
- Zapparoli M, "3.0-T MRI evaluation of patients with chronic liver diseases : initial observations", Magn Reson Imaging, 26, pp.650~660 (2008)
- Hahn PF, "Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors", Radiology, 174, pp.361~366 (1990)
- Schneider G, "Contrast agents in abdominal imaging-current and future directions", Top Magn Reson Imaging, 16, pp.107~124 (2005)
- Bellin MF, "Liver metastases: safety and Efficacy of detection with superparamagnetic iron oxide in MR imaging", Radiology, 193, pp.657~663 (1994)
- Matsuo M, "Detection of malignant hepatic tumors with ferumoxides-enhanced MRI: Comparison of five gradient-recalled echo sequences with different TEs", AJR Am J Roentgenol, 182, pp.235~242 (2004)
- Yoshikawa T, "Gradient- and spin-echo T2-weighted imaging for SPIO-enhanced detection and characterization of focal liver lesions", J Magn Reson Imaging, 23, pp.712~719 (2006)
- Ward J, "Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternativefree response receiver operating characteristic analysis", Radiology, 214, pp.159~166 (2000)
- Kurokawa H, "Experimental study of fast and ultrafast T2-weighted imaging sequences using AMI-25 superparamagnetic iron oxide (SPIO)", Acta Med Okayama, 55, pp.41~50 (2001)
- Kumano S, "Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions", AJR Am J Roentgenol, 181, pp.1335~1339 (2003)
- Tanimoto A, "Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function", Radiology, 222, pp.661~666 (2002)
- Kanematsu M, "Malignant hepatic tumor detection with ferumoxides-enhanced MR imaging with a 1.5-T system: comparison of four imaging pulse sequences", J Magn Reson Imaging, 13, pp.249~257 (2001)
- Elizondo G, "Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide", Radiology, 174, pp.797~801 (1990)
- Zech CJ, "hoenberg SO. Black-blood diffusion-weighted EPI acquisition of the liver with paraller imaging. Comparison with a standard T2-weighted sequence for detection of focal liver lesions", Invest Radiol, 43, pp.261~266 (2008)
- Kuwatsuru R, "Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents", Radiology, 202, pp.131~138 (1997)
- Tanimoto A, , Radiology, 222, pp.661~666 (2002)
- Tanimoto A, "Relaxation effects of clustered particles", J Magn Reson Imaging, 14, pp.72~77 (2001)
- Tang Y, "Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium and ferumoxides-enhanced MR imaging", AJR Am J Roentgenol, 172, pp.1547~1554 (1999)